Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Notice they are heading to P2 and some here think Sareum will be bought out after a CTA notice. There is still a lot of meat left on this bone.
I had a part to play in this and I'm annoyed at myself for rising to Rucks post. I apologise for adding fuel to the fire and dragging a bit of that bile over here. I don't post or even look at that BB anymore because it's just the most toxic place. It's not only the Scancell BB but pretty much all of them there. Anonymous, unmoderated BB's seem to show people at their worst with the most basic of insults, crude language and dubious philosophies.
Let's leave what is there, there and comment on that content there too. As C7 says we are free to read and post there if we like. This BB deserves better.
Grover,
Because this is is a high risk share. Most people are risk averse so there are not a lot of shareholders. When there is no news this will drift down as traders and MM's play around. When there is good news then the FOMO kicks in as it's suddenly seen as "less risky" for a bit and then the decline begins again.
If you want to make money then buy when you feel like selling and are losing hope and sell when everything is great.
Mafuta,
The thing is, they said that companies were looking for later stage deals rather than earlier stage deals and that at "the latest" Sareum would look to license or at mid to late clinical stage development. They will however never take a product onto the market. This would all be weighed up as to what was on offer but if the right deal came along at an earlier stage then they would take it. (Listen at 32.20).
That little "Please note that our model is to license at the pre-clinical or early clinical stage" at the end of the typed Q&A was not said in the meeting. It just makes me think there there could still be a lot of meat left on this bone. Phase 1b will only be completed in 2024 and if they go to P2 then......................
But then we'll all get a lot more for our investment.
A much appreciated response Burble, thanks.
MattRempit - AZ signed an agreement with Oxford University (Sarah Gilbert/Vaccitech) to distribute the vaccine on a not-for-profit basis.
It does seem ike AZ need to go shopping if they want to stay in the Covid vaccine market though.
https://www.edisongroup.com/publication/sdc-1801-cta-filed-in-the-uk/31161/
ImmunityBio seem to be a very similar company to Scancell and they have a market cap of $1.68 billion. Their trials progress is a bit better across their portfolio and they have not marketed anything yet, but are close. It really does make one think about Scancells current SP.
PCS1954,
Oh dear, here we go again... I really wish someone was paying me to post on here. We all have different styles of investing and trading. Some use technicals, others news, hope or belief. I use the TA at the moment to accumulate. I'm already in the game but if (and again I say If) it goes back to £1.20 I will buy more. I originally bought because I believe in the science, but why pay a premium for more shares if I don't need to?
Like it or not, £1.20 is a very important level on the Sareum chart. No matter how much beer you drink that will not change.